Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

NCT00091819 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

862

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Skin Infection

Interventions

DRUG: Telavancin
DRUG: Vancomycin

Sponsor

Cumberland Pharmaceuticals